| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 440.59B | 436.71B | 406.03B | 366.39B | 322.32B |
| Gross Profit | 51.59B | 53.90B | 51.31B | 45.50B | 42.41B |
| EBITDA | 28.03B | 27.15B | 26.89B | 25.07B | 21.07B |
| Net Income | 5.69B | 8.40B | 7.99B | 7.82B | 6.50B |
Balance Sheet | |||||
| Total Assets | 942.22B | 869.00B | 783.16B | 664.35B | 528.86B |
| Cash, Cash Equivalents and Short-Term Investments | 94.42B | 91.58B | 77.71B | 78.39B | 61.49B |
| Total Debt | 359.17B | 290.34B | 244.19B | 192.97B | 124.10B |
| Total Liabilities | 740.18B | 663.18B | 594.90B | 496.86B | 379.13B |
| Stockholders Equity | 111.53B | 116.01B | 110.46B | 101.89B | 94.20B |
Cash Flow | |||||
| Free Cash Flow | -28.58B | -34.49B | -21.64B | -12.05B | -5.20B |
| Operating Cash Flow | 12.03B | 11.03B | 9.49B | 7.93B | 8.84B |
| Investing Cash Flow | -32.10B | -50.34B | -41.53B | -49.03B | -18.65B |
| Financing Cash Flow | 21.05B | 53.36B | 36.05B | 52.32B | 12.32B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | HK$28.47B | 17.27 | 5.62% | 5.31% | 11.89% | 8.49% | |
62 Neutral | HK$47.17B | 4.99 | 11.89% | 6.69% | -5.14% | -4.05% | |
52 Neutral | HK$142.62B | 4.06 | 6.46% | 7.43% | -7.46% | -21.80% | |
48 Neutral | HK$84.33B | 6.98 | 7.17% | 3.90% | 11.49% | -7.01% | |
44 Neutral | HK$66.58B | 5.71 | 0.95% | 3.21% | -18.36% | -47.29% | |
44 Neutral | HK$19.52B | 100.11 | 2.33% | ― | -1.75% | ― |